Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0MF9H
|
|||
Former ID |
DIB006194
|
|||
Drug Name |
Delucemine
|
|||
Synonyms |
Delucemine hydrochloride; NPS-1506
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Depression [ICD-11: 6A70-6A7Z; ICD-9: 311] | Discontinued in Phase 1 | [1] | |
Company |
NPS Pharmaceuticals Inc
|
|||
Structure |
Download2D MOL |
|||
Formula |
C16H17F2N
|
|||
Canonical SMILES |
CNCCC(C1=CC(=CC=C1)F)C2=CC(=CC=C2)F
|
|||
InChI |
1S/C16H17F2N/c1-19-9-8-16(12-4-2-6-14(17)10-12)13-5-3-7-15(18)11-13/h2-7,10-11,16,19H,8-9H2,1H3
|
|||
InChIKey |
MUGNLPWYHGOJEG-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 186495-49-8
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | N-methyl-D-aspartate receptor (NMDAR) | Target Info | Modulator | [2] |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800009310) | |||
REF 2 | NPS 1506, a novel NMDA receptor antagonist and neuroprotectant. Review of preclinical and clinical studies. Ann N Y Acad Sci. 1999;890:450-7. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.